hydroxyproline has been researched along with nafarelin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hirvonen, E; Nilsson, CG; Viinikka, L; Ylikorkala, O | 1 |
| Heinrichs, L; Henzl, M; Holloway, L; Marcus, R; Monroe, SE; Newhall-Perry, K; Osburn, L | 1 |
1 trial(s) available for hydroxyproline and nafarelin
| Article | Year |
|---|---|
Evidence of similar increases in bone turnover during nafarelin and danazol use in women with endometriosis.
Topics: Alkaline Phosphatase; Analysis of Variance; Bone Density; Bone Regeneration; Calcitonin; Calcium; Danazol; Endometriosis; Female; Gonadotropin-Releasing Hormone; Humans; Hydroxyproline; Middle Aged; Nafarelin; Osteocalcin; Osteoporosis, Postmenopausal; Parathyroid Hormone; Peptide Fragments; Procollagen | 1990 |
1 other study(ies) available for hydroxyproline and nafarelin
| Article | Year |
|---|---|
Effects of a gonadotropin-releasing hormone agonist on the calcium-parathyroid axis and bone turnover in women with endometriosis.
Topics: Adult; Bone and Bones; Bone Density; Bone Remodeling; Calcitriol; Calcium; Endometriosis; Female; Gonadotropin-Releasing Hormone; Hormones; Humans; Hydroxyproline; Kinetics; Nafarelin; Osteocalcin; Parathyroid Hormone | 1995 |